Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer

BACKGROUND: Gastric cancer (GC) is the fourth most common cause of cancer deaths around the world and the first cause of cancer deaths in Peru; however, there are no prospective trials for adjuvant chemotherapy in GC after curative gastrectomy in this country. The objective of this study was to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrano, Mariana, Araujo, Jhajaira M, Pacheco, Cristian, Macetas, Jackeline, Blum, Mariella A, Carrato, Alfredo, Ruiz, Eloy, Berrospi, Francisco, Luque, Carlos, Chavez, Ivan, Payet, Eduardo, Taxa, Luis, Montenegro, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300408/
https://www.ncbi.nlm.nih.gov/pubmed/35919233
http://dx.doi.org/10.3332/ecancer.2022.1387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300408/
https://www.ncbi.nlm.nih.gov/pubmed/35919233
http://dx.doi.org/10.3332/ecancer.2022.1387

Ejemplares similares